Desmethylcitalopram
![]()  | |
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Legal status | |
| Legal status | 
  | 
| Pharmacokinetic data | |
| Elimination half-life | 50 h | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.057.776 | 
| Chemical and physical data | |
| Formula | C19H19FN2O | 
| Molar mass | 310.372 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
|   | |
Desmethylcitalopram is an active metabolite of the antidepressant drugs citalopram (racemic) and escitalopram (the S-enantiomer, which would be called desmethylescitalopram).[1][2] Like citalopram and escitalopram, desmethylcitalopram functions as a selective serotonin reuptake inhibitor (SSRI), and is responsible for some of its parents' therapeutic benefits.
See also
References
- ↑ "Desmethylcitalopram". Human Metabolome Database.
 - ↑ Brøsen K, Naranjo CA (August 2001). "Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram". European Neuropsychopharmacology. 11 (4): 275–83. doi:10.1016/s0924-977x(01)00101-8. PMID 11532381. S2CID 11837037.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

